Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Current Opinion in Hematology
|
May 24, 2016
Telomerase in hematologic malignancies
Claudia Bruedigam, Steven W Lane
Genomics Data
|
March 17, 2016
Analysis of telomerase target gene expression effects from murine models in patient cohorts by homology translation and random survival forest modeling
Frederik Otzen Bagger, Claudia Bruedigam, Steven W Lane
Cells
|
October 27, 2023
Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health
Claudia Bruedigam, Johannes P T M van Leeuwen, Jeroen van de Peppel
Methods in Molecular Biology (Clifton, N.J.)
|
February 23, 2024
Modeling Acute Myeloid Leukemia Using StarPEG-Heparin Hydrogels
P Lewen Holloway, Akhilandeshwari Ravichandran, Julien Clegg, et al.
Journal of Molecular and Cellular Cardiology
|
August 6, 2011
Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells
Claudia Bruedigam, Marco Eijken, Marijke Koedam, et al.
FEBS Letters
|
April 26, 2008
Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability
Claudia Bruedigam, Marijke Koedam, Hideki Chiba, et al.
Blood Advances
|
May 22, 2023
Telomerase-targeted therapies in myeloid malignancies
Julian A Waksal, Claudia Bruedigam, Rami S Komrokji, et al.
Plant Physiology
|
September 13, 2003
Metabolic profiling of transgenic tomato plants overexpressing hexokinase reveals that the influence of hexose phosphorylation diminishes during fruit development
Ute Roessner-Tunali, Björn Hegemann, Anna Lytovchenko, et al.
Stem Cells (Dayton, Ohio)
|
March 10, 2010
A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone
Claudia Bruedigam, Marco Eijken, Marijke Koedam, et al.
Plos One
|
June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
Sara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Current Opinion in Hematology
|
May 24, 2016
Telomerase in hematologic malignancies
Claudia Bruedigam, Steven W Lane
Genomics Data
|
March 17, 2016
Analysis of telomerase target gene expression effects from murine models in patient cohorts by homology translation and random survival forest modeling
Frederik Otzen Bagger, Claudia Bruedigam, Steven W Lane
Cells
|
October 27, 2023
Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health
Claudia Bruedigam, Johannes P T M van Leeuwen, Jeroen van de Peppel
Methods in Molecular Biology (Clifton, N.J.)
|
February 23, 2024
Modeling Acute Myeloid Leukemia Using StarPEG-Heparin Hydrogels
P Lewen Holloway, Akhilandeshwari Ravichandran, Julien Clegg, et al.
Journal of Molecular and Cellular Cardiology
|
August 6, 2011
Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells
Claudia Bruedigam, Marco Eijken, Marijke Koedam, et al.
FEBS Letters
|
April 26, 2008
Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability
Claudia Bruedigam, Marijke Koedam, Hideki Chiba, et al.
Blood Advances
|
May 22, 2023
Telomerase-targeted therapies in myeloid malignancies
Julian A Waksal, Claudia Bruedigam, Rami S Komrokji, et al.
Plant Physiology
|
September 13, 2003
Metabolic profiling of transgenic tomato plants overexpressing hexokinase reveals that the influence of hexose phosphorylation diminishes during fruit development
Ute Roessner-Tunali, Björn Hegemann, Anna Lytovchenko, et al.
Stem Cells (Dayton, Ohio)
|
March 10, 2010
A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone
Claudia Bruedigam, Marco Eijken, Marijke Koedam, et al.
Plos One
|
June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
Sara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Page
of 3